Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
出版年份 2017 全文链接
标题
Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-05-15
DOI
10.3389/fonc.2017.00094
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
- (2015) J. J. Tentler et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of the Novel Senescence Marker β-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence
- (2015) Jennifer Wagner et al. PLoS One
- Cellular senescence and its effector programs
- (2014) R. Salama et al. GENES & DEVELOPMENT
- Functional interplay between MDM2, p63/p73 and mutant p53
- (2014) M H Stindt et al. ONCOGENE
- Aurora A is involved in central spindle assembly through phosphorylation of Ser 19 in P150Glued
- (2013) David Reboutier et al. JOURNAL OF CELL BIOLOGY
- Integrity of p53 Associated Pathways Determines Induction of Apoptosis of Tumor Cells Resistant to Aurora-A Kinase Inhibitors
- (2013) Yoshimi Shionome et al. PLoS One
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
- (2012) Peter Kabos et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
- (2012) J. R. Diamond et al. CLINICAL CANCER RESEARCH
- Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
- (2012) Makoto Taga et al. International Journal of Biological Sciences
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple negative breast cancer - prognostic factors and survival
- (2011) Tanja Ovcaricek et al. Radiology and Oncology
- Quantitative assessment of markers for cell senescence
- (2010) Conor Lawless et al. EXPERIMENTAL GERONTOLOGY
- Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation
- (2010) Jennifer J. Jordan et al. MOLECULAR CANCER RESEARCH
- ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action
- (2010) G. C. Fletcher et al. MOLECULAR CANCER THERAPEUTICS
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel
- (2009) Ewan K.A. Millar et al. JOURNAL OF CLINICAL ONCOLOGY
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
- (2009) Francis Rodier et al. NATURE CELL BIOLOGY
- Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
- (2008) Altaf A. Dar et al. CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started